Philip Griffin

Changes in Human Immunodeficiency Virus Type 1 Gag at Positions L449 and P453 Are Linked to I50V Protease Mutants In Vivo and Cause Reduction of Sensitivity to Amprenavir and Improved Viral Fitness In Vitro

Michael Maguire, Rosario Guinea, Philip Griffin et al. · Journal of Virology · 2002 · 158 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +17

HIV-1 reverse transcriptase (RT) genotype and susceptibility to RT inhibitors during abacavir monotherapy and combination therapy

Veronica Miller, Mounir Ait‐Khaled, Christopher Stone et al. · AIDS · 2000 · 130 citations

Life Sciences, Pharmacology, Pharmacotherapy +17

Poly(A) site selection in the HIV-1 provirus: inhibition of promoter-proximal polyadenylation by the downstream major splice donor site.

Mark Ashe, Philip Griffin, William James et al. · Genes & Development · 1995 · 122 citations · Full text

Life Sciences, Genetics, Molecular Biology +17

Cytotoxic T Lymphocyte Lysis Inhibited by Viable HIV Mutants

Ute‐Christiane Meier, Paul Klenerman, Philip Griffin et al. · Science · 1995 · 110 citations

Life Sciences, Immunology, Infectious Diseases +17

The bicyclams, a new class of potent human immunodeficiency virus inhibitors, block viral entry after binding

K De Vreese, D. Reymen, Philip Griffin et al. · Antiviral Research · 1996 · 56 citations

Medicine, Medicinal Chemistry, Pharmacology +16